(Q37947720)

25 August 2017

title

Pathological roles of α-synuclein in neurological disorders (English)

1 reference

25 August 2017

1 reference

Kostas Vekrellis

1

1 reference

25 August 2017

Maria Xilouri

2

1 reference

25 August 2017

Evangelia Emmanouilidou

3

1 reference

25 August 2017

Hardy J Rideout

4

1 reference

25 August 2017

Leonidas Stefanis

5

1 reference

25 August 2017

publication date

1 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

10

1 reference

25 August 2017

issue

11

1 reference

25 August 2017

page(s)

1015-1025

1 reference

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Neurobiology of alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

The genetics of Parkinson's syndromes: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

SNCA variants are associated with increased risk for multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

alpha-Synucleinopathy models and human neuropathology: similarities and differences

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

In vivo demonstration that alpha-synuclein oligomers are toxic

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

A novel pathway for transcriptional regulation of alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Functional dissection of the alpha-synuclein promoter: transcriptional regulation by ZSCAN21 and ZNF219

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

α-Synuclein expression is induced by depolarization and cyclic AMP in enteric neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Repression of alpha-synuclein expression and toxicity by microRNA-7.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Protein degradation, aggregation, and misfolding

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

α-Synuclein Is Degraded by Both Autophagy and the Proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Chaperone-mediated autophagy markers in Parkinson disease brains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Lysosomal degradation of alpha-synuclein in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

alpha-synuclein promotes mitochondrial deficit and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

α-Synuclein impairs macroautophagy: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Localization of alpha-synuclein to mitochondria within midbrain of mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Semi-quantitative analysis of alpha-synuclein in subcellular pools of rat brain neurons: an immunogold electron microscopic study using a C-terminal specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

alpha-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

The transgenic overexpression of alpha-synuclein and not its related pathology associates with complex I inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Mitochondrial α-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Parkin deficiency delays motor decline and disease manifestation in a mouse model of synucleinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Oligomeric alpha-synuclein inhibits tubulin polymerization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Impairment of microtubule system increases alpha-synuclein aggregation and toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Tubulin seeds alpha-synuclein fibril formation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Signal transduction protein array analysis links LRRK2 to Ste20 kinases and PKC zeta that modulate neuronal plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ß.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Parkinsonism, Lrrk2 G2019S, and tau neuropathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

A pathologic cascade leading to synaptic dysfunction in alpha-synuclein-induced neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Different species of alpha-synuclein oligomers induce calcium influx and seeding.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

alpha-Synuclein modulation of Ca2+ signaling in human neuroblastoma (SH-SY5Y) cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

AMPA-receptor-mediated excitatory synaptic transmission is enhanced by iron-induced α-synuclein oligomers.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

'Rejuvenation' protects neurons in mouse models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Calcium homeostasis, selective vulnerability and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein overexpression increases cytosolic catecholamine concentration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Heat‐shock protein 70 modulates toxic extracellular α‐synuclein oligomers and rescues trans‐synaptic toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Intravesicular localization and exocytosis of alpha-synuclein and its aggregates.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Exosomes--vesicular carriers for intercellular communication

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

Assessment of α-synuclein secretion in mouse and human brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970213-7

7 January 2021

10.1016/S1474-4422(11)70213-7

Identifiers

DOI

1 reference

25 August 2017

1 reference